These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18281552)

  • 1. Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.
    Boller D; Schramm A; Doepfner KT; Shalaby T; von Bueren AO; Eggert A; Grotzer MA; Arcaro A
    Clin Cancer Res; 2008 Feb; 14(4):1172-81. PubMed ID: 18281552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the PI3K p110alpha isoform inhibits medulloblastoma proliferation, chemoresistance, and migration.
    Guerreiro AS; Fattet S; Fischer B; Shalaby T; Jackson SP; Schoenwaelder SM; Grotzer MA; Delattre O; Arcaro A
    Clin Cancer Res; 2008 Nov; 14(21):6761-9. PubMed ID: 18980969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of class I phosphoinositide 3-kinase activity impairs proliferation and triggers apoptosis in acute promyelocytic leukemia without affecting atra-induced differentiation.
    Billottet C; Banerjee L; Vanhaesebroeck B; Khwaja A
    Cancer Res; 2009 Feb; 69(3):1027-36. PubMed ID: 19176369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
    Hill KM; Kalifa S; Das JR; Bhatti T; Gay M; Williams D; Taliferro-Smith L; De Marzo AM
    Prostate; 2010 May; 70(7):755-64. PubMed ID: 20058239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
    Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
    Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of breast cancer cell chemotaxis by the phosphoinositide 3-kinase p110delta.
    Sawyer C; Sturge J; Bennett DC; O'Hare MJ; Allen WE; Bain J; Jones GE; Vanhaesebroeck B
    Cancer Res; 2003 Apr; 63(7):1667-75. PubMed ID: 12670921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of Akt predicts poor outcome in neuroblastoma.
    Opel D; Poremba C; Simon T; Debatin KM; Fulda S
    Cancer Res; 2007 Jan; 67(2):735-45. PubMed ID: 17234785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A selective inhibitor of the p110delta isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16.
    Billottet C; Grandage VL; Gale RE; Quattropani A; Rommel C; Vanhaesebroeck B; Khwaja A
    Oncogene; 2006 Oct; 25(50):6648-59. PubMed ID: 16702948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor effects of Isatin on human neuroblastoma cell line (SH-SY5Y) and the related mechanism.
    Hou L; Ju C; Zhang J; Song J; Ge Y; Yue W
    Eur J Pharmacol; 2008 Jul; 589(1-3):27-31. PubMed ID: 18561913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice.
    Okkenhaug K; Bilancio A; Farjot G; Priddle H; Sancho S; Peskett E; Pearce W; Meek SE; Salpekar A; Waterfield MD; Smith AJ; Vanhaesebroeck B
    Science; 2002 Aug; 297(5583):1031-4. PubMed ID: 12130661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. delta-Opioid receptor-stimulated Akt signaling in neuroblastoma x glioma (NG108-15) hybrid cells involves receptor tyrosine kinase-mediated PI3K activation.
    Heiss A; Ammer H; Eisinger DA
    Exp Cell Res; 2009 Jul; 315(12):2115-25. PubMed ID: 19362548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death.
    Kang S; Song J; Kang J; Kang H; Lee D; Lee Y; Park D
    Biochem Biophys Res Commun; 2005 Apr; 329(1):6-10. PubMed ID: 15721265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
    Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
    Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Akt induces apoptosis in neuroblastoma cells expressing a C98X vasopressin mutant following autophagy suppression.
    Castino R; Thepparit C; Bellio N; Murphy D; Isidoro C
    J Neuroendocrinol; 2008 Oct; 20(10):1165-75. PubMed ID: 18673414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross-talking with RANK signaling.
    Yi T; Lee HL; Cha JH; Ko SI; Kim HJ; Shin HI; Woo KM; Ryoo HM; Kim GS; Baek JH
    J Cell Physiol; 2008 Nov; 217(2):409-22. PubMed ID: 18543257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells by multi-kinase targeting.
    Cassinelli G; Ronchetti D; Laccabue D; Mattioli M; Cuccuru G; Favini E; Nicolini V; Greco A; Neri A; Zunino F; Lanzi C
    Biochem Pharmacol; 2009 Nov; 78(9):1139-47. PubMed ID: 19555670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiofrequency radiation (900 MHz) induces Egr-1 gene expression and affects cell-cycle control in human neuroblastoma cells.
    Buttiglione M; Roca L; Montemurno E; Vitiello F; Capozzi V; Cibelli G
    J Cell Physiol; 2007 Dec; 213(3):759-67. PubMed ID: 17559061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimyeloma activity of the orally bioavailable dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235.
    McMillin DW; Ooi M; Delmore J; Negri J; Hayden P; Mitsiades N; Jakubikova J; Maira SM; Garcia-Echeverria C; Schlossman R; Munshi NC; Richardson PG; Anderson KC; Mitsiades CS
    Cancer Res; 2009 Jul; 69(14):5835-42. PubMed ID: 19584292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/AKT/survivin pathway in colon cancer cells.
    Wang J; Yang L; Yang J; Kuropatwinski K; Wang W; Liu XQ; Hauser J; Brattain MG
    Cancer Res; 2008 May; 68(9):3152-60. PubMed ID: 18451140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.